FDA Inspection
Antares Pharma, IncAntares Pharma, Inc – FDA Inspection, Jan 16, 2025
Record Details
This FDA Inspection record concerns Antares Pharma, Inc, with an inspection on January 16, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · a7937fcd-171d-4503-8be5-3396181711b9
Inspection Facts
- Inspection number
- 1257757
- FDA center
- Human Drugs
Other FDA inspections of Antares Pharma, Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 4, 2018 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| January 21, 2016 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| September 6, 2012 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| July 14, 2009 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Antares Pharma, Inc
- FDA Inspection 1073695 - 2018-12-04
- FDA Inspection 963398 - 2016-01-21
- FDA Inspection 798055 - 2012-09-06
- FDA Inspection 596396 - 2009-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.